HKD36.10
1.98% today
Hong Kong, Aug 12, 10:08 am CET
ISIN
KYG549581067
Symbol
3692
Index

Hansoh Pharmaceutical Group Company Stock price

HKD36.10
+3.50 10.74% 1M
+18.80 108.67% 6M
+18.82 108.91% YTD
+17.60 95.14% 1Y
+20.22 127.33% 3Y
+4.10 12.81% 5Y
+16.60 85.13% 10Y
+16.60 85.13% 20Y
Hong Kong, Closing price Tue, Aug 12 2025
+0.70 1.98%
ISIN
KYG549581067
Symbol
3692
Index
Industry

Key metrics

Basic
Market capitalization
HKD210.4b
Enterprise Value
HKD185.0b
Net debt
positive
Cash
HKD25.5b
Shares outstanding
5.9b
Valuation (TTM | estimate)
P/E
44.3 | 42.4
P/S
15.7 | 13.8
EV/Sales
13.8 | 12.2
EV/FCF
49.5
P/B
6.7
Dividends
DPS
HKD0.34
Yield 1Y | 5Y
1.0% | 0.6%
Growth 1Y | 5Y
184.3% | -
Payout 1Y | 3Y
58.2% | 39.0%
Increased
1 Year
Financials (TTM | estimate)
Revenue
HKD13.4b | HKD15.2b
EBITDA
HKD4.8b | HKD5.4b
EBIT
HKD4.4b | HKD5.1b
Net Income
HKD4.8b | HKD5.0b
Free Cash Flow
HKD3.7b
Growth (TTM | estimate)
Revenue
21.4% | 13.7%
EBITDA
44.4% | 12.5%
EBIT
49.2% | 17.1%
Net Income
33.4% | 3.8%
Free Cash Flow
18.1%
Margin (TTM | estimate)
Gross
90.9%
EBITDA
35.9% | 35.5%
EBIT
32.6%
Net
35.7% | 32.5%
Free Cash Flow
27.9%
Financial Health
Equity Ratio
90.6%
Return on Equity
15.2%
ROCE
13.8%
ROIC
44.5%
Debt/Equity
0.0
More
EPS
HKD0.8
FCF per Share
HKD0.6
Short interest
-
Employees
9k
Rev per Employee
HKD1.5m
Show more

Is Hansoh Pharmaceutical Group Company a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

Hansoh Pharmaceutical Group Company Stock Analysis

Unlock Scores for Free

Analyst Opinions

28 Analysts have issued a Hansoh Pharmaceutical Group Company forecast:

26x Buy
93%
2x Hold
7%

Analyst Opinions

28 Analysts have issued a Hansoh Pharmaceutical Group Company forecast:

Buy
93%
Hold
7%

Financial data from Hansoh Pharmaceutical Group Company

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
13,389 13,389
21% 21%
100%
- Direct Costs 1,219 1,219
8% 8%
9%
12,170 12,170
23% 23%
91%
- Selling and Administrative Expenses 4,903 4,903
5% 5%
37%
- Research and Development Expense 2,950 2,950
29% 29%
22%
4,800 4,800
44% 44%
36%
- Depreciation and Amortization 438 438
10% 10%
3%
EBIT (Operating Income) EBIT 4,362 4,362
49% 49%
33%
Net Profit 4,774 4,774
33% 33%
36%

In millions HKD.

Don't miss a Thing! We will send you all news about Hansoh Pharmaceutical Group Company directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Hansoh Pharmaceutical Group Co., Ltd. is a holding company, which engages in the research and development, production, and sale of a series of pharmaceutical products. Its products include oncology, anti-infective, anti-diabetic, gastrointestinal, and cardiovascular drugs. The company was founded by Huijuan Zhong on December 2, 2015 and is headquartered in Lianyungang, China.

Head office Cayman Islands
CEO Hui Zhong
Employees 8,989
Founded 2015
Website www.hspharm.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today